Therapeutic use of electroacupuncture-induced mesenchymal stem cells

US11654159B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11654159-B2
Application numberUS-201716092119-A
CountryUS
Kind codeB2
Filing dateApr 6, 2017
Priority dateApr 6, 2016
Publication dateMay 23, 2023
Grant dateMay 23, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Stimulation using EA of LI-4, LI-11, GV-14 and GV-20 in humans, horses, and rodents results in mobilization of MSCs into systemic circulation. Methods are provided for increasing mesenchymal stem cells in the circulating blood of a mammal by contacting acupuncture points LI-4, LI-11, GV-14, and GV-20 of the mammal with a therapeutically effective amount of EA stimulation to mobilize MSCs into the circulating blood of the mammal. Methods for treating damaged tissue, specifically damaged tendons are also provided. Isolated mesenchymal stem cells made according to these methods, methods of isolated them, and stem cell banks that store them are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of increasing mesenchymal stem cells in the circulating blood of a mammal comprising contacting two or more acupuncture points of the group consisting of LI-4, LI-11, GV-14, and GV-20 of the mammal with a therapeutically effective amount of electroacupuncture stimulation to mobilize mesenchymal stem cells into the circulating blood of the mammal. 2. The method of claim 1 , wherein the therapeutically effective amount of electroacupuncture stimulation is from about 15-25 hz for 10 to 60 minutes. 3. The method of claim 1 , wherein the mammal is selected is selected from the group consisting of: humans, horses, rats, and mice. 4. A method of isolating mesenchymal stem cells from the peripheral blood of a mammal to yield electroacupuncture-mobilized mesenchymal stem cells comprising the steps of: (a) contacting two or more acupuncture points from the group consisting of LI-4, LI-11, GV-14, and GV-20 in the mammal with a therapeutically effective amount of electroacupuncture-induced stimulation; (b) collecting the peripheral blood from the mammal after stimulation; (c) separating peripheral blood mononuclear cells from the blood and exposing the cells to conditions that generate formation of mesenchymal colonies. 5. The method of claim 4 , wherein said conditions that promote mesenchymal stem cell formation comprise culturing said peripheral blood mononuclear cells in the presence of a combination of Ham's F-12 and DMEM in a 1:1 ratio optionally with 15% Fetal Bovine Serum. 6. The method of claim 4 , wherein the electroacupuncture is applied for 20-50 minutes. 7. The method of claim 4 , wherein the electroacupuncture is applied at 0.5-3.5 mA. 8. The method of claim 4 , further comprising treating damaged tissue in a mammal by contacting the damaged tissue with mesenchymal stem cells of claim 7 , wherein said contacting is by direct injection into the area of the damaged tissue, intraparentoneal injection, intramuscular injection, or by intravenous injection. 9. The method of claim 8 , wherein said damaged tissue is the result of injury, or trauma, or disease. 10. The method of claim 8 , wherein the damaged tissue is a damaged tendon. 11. A method of treating damaged tissue or inflammation in a mammal, the method comprising increasing mesenchymal stem cells in the circulating blood of a mammal by contacting two or more acupuncture points selected from the group consisting of LI-4, LI-11, GV-14, and GV-20 of the mammal with a therapeutically effective amount of electroacupuncture stimulation to mobilize mesenchymal stem cells into the circulating blood of the mammal. 12. The method of claim 11 wherein electroacupuncture is applied at 15-25 Hz for 10-60 minutes. 13. The method of claim 11 , wherein the electroacupuncture is applied at 0.5-3.5 Ma. 14. The method of claim 11 , wherein electroacupuncture stimulation is applied simulataneously to acupuncture points LI-4, LI-11, GV-14 and GV-20.

Assignees

Inventors

Classifications

  • Culture process characterised by the use of electromagnetic stimulation · CPC title

  • Acupuncture needles · CPC title

  • especially adapted for animals · CPC title

  • with leads or electrodes penetrating the skin · CPC title

  • A61H39/002Primary

    Using electric currents (electrotherapy A61N1/32) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11654159B2 cover?
Stimulation using EA of LI-4, LI-11, GV-14 and GV-20 in humans, horses, and rodents results in mobilization of MSCs into systemic circulation. Methods are provided for increasing mesenchymal stem cells in the circulating blood of a mammal by contacting acupuncture points LI-4, LI-11, GV-14, and GV-20 of the mammal with a therapeutically effective amount of EA stimulation to mobilize MSCs into t…
Who is the assignee on this patent?
Univ Florida
What technology area does this patent fall under?
Primary CPC classification A61H39/002. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).